Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer

Table 1

The clinical characteristics of patients with non-small cell lung cancer.

	Number	Proportion (%)
Number	188
NSCLC type
Adenocarcinoma	102	54.25
Squamous cell	55	29.25
Others	31	16.50
Stage of NSCLC
<IIIb	80	42.55
≥IIIb	108	57.45
Complicating DVT
Yes	41	21.80
With metastasis	31	75.61
Without metastasis	10	24.39
No	147	78.20
Tumor metastasis
Yes	66	35.11
With DVT	31	46.97
Without DVT	35	53.03
No	122	64.89

NSCLC: non-small cell lung cancer. DVT: deep venous thrombosis. value: compared with patients with metastasis, respectively. .